Literature DB >> 40150

Abnormalities of neurotransmitter enzymes in Huntington's chorea.

J Y Wu, E D Bird, M S Chen, W M Huang.   

Abstract

The activities of L-glutamate decarboxylase (GAD), GABA-transaminase (GABA-T), choline acetyltransferase (CAT), and cysteic and cysteinesulfinic acids decarboxylase (CAD/CSAD) in putamen and frontal cortex in both Huntington's chorea and normal tissues were measured. The greatest difference between Huntington's and normal tissues occurred in putamen, in which the apparent CSAD activity was reduced by 85%, while no difference was observed in frontal cortex. GAD, CAD, and CAT activities were also reduced in putamen by 65%, 63%, and 42%, respectively (P less than 0.05). Slight reduction in the enzyme activities was also observed in frontal cortex. However, these reductions appeared to be statistically insignificant (P greater than 0.05 in all cases). GABA-T showed little difference in both putamen and frontal cortex in Huntington's chorea and normal tissues. GAD and GABA-T from Huntington's tissues were indistinguishable from those obtained from normal tissues by double diffusion test and by microcomplement fixation test, which is capable of distinguishing proteins with a single amino acid substitution. Furthermore, the similarity of the complement fixation curves for GAD from Huntington's and normal tissues suggests that the decrease in GAD activity is probably due to the reduction in the number of GAD molecules, presumably through the loss of neurons, and not due to the inhibition or inactivation of GAD activity by toxic substances which might be present in Huntington's chorea.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40150     DOI: 10.1007/bf00964435

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

Authors:  J T Coyle; R Schwarcz
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

2.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids.

Authors:  E G McGeer; P L McGeer
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

3.  A rapid method for assaying enzymes whose substrates and products differ by charge. Application to brain L-glutamate decarboxylase.

Authors:  O Chude; J Y Wu
Journal:  J Neurochem       Date:  1976-07       Impact factor: 5.372

4.  Tissue and regional distribution of cysteic acid decarboxylase. A new assay method.

Authors:  J Y Wu; L G Moss; M S Chen
Journal:  Neurochem Res       Date:  1979-04       Impact factor: 3.996

5.  Immunochemical comparisons of vertebrate glutamic acid decarboxylase.

Authors:  K Saito; J Y Wu; T Matsuda; E Roberts
Journal:  Brain Res       Date:  1974-01-11       Impact factor: 3.252

6.  Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study.

Authors:  P L McGeer; E G McGeer; H C Fibiger
Journal:  Neurology       Date:  1973-09       Impact factor: 9.910

7.  Some immunochemical properties and species specificity of GABA-alpha-ketoglutarate transaminase from mouse brain.

Authors:  K Saito; A Schousboe; J Y Wu; E Roberts
Journal:  Brain Res       Date:  1974-01-11       Impact factor: 3.252

8.  Purification and properties of choline acetyltransferase from Torpedo californica.

Authors:  C Brandon; J Y Wu
Journal:  J Neurochem       Date:  1978-04       Impact factor: 5.372

9.  Immunocytochemical localization of gamma-aminobutyric acid transaminase at cellular and ultrastructural levels.

Authors:  V Chan-Palay; J Y Wu; S L Palay
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  Pyridoxal phosphate as the coenzyme of the mammalian decarboxylase for L-cysteine sulphinic and L-cysteic acids.

Authors:  D B HOPE
Journal:  Biochem J       Date:  1955-03       Impact factor: 3.857

View more
  7 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

Review 2.  Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs.

Authors:  Hyunbeom Lee; Jose I Juncosa; Richard B Silverman
Journal:  Med Res Rev       Date:  2014-08-22       Impact factor: 12.944

3.  Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.

Authors:  Hejun Lu; Richard B Silverman
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

4.  Structural modifications of (1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid, a potent irreversible inhibitor of GABA aminotransferase.

Authors:  Hai Yuan; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2007-01-17       Impact factor: 2.823

5.  Resolution and purification of taurine- and GABA-synthesizing decarboxylases from calf brain.

Authors:  A A Heinämäki; S I Malila; K M Tolonen; K H Valkonen; R S Piha
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

6.  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.

Authors:  Dustin D Hawker; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-08-16       Impact factor: 3.641

7.  Stereochemical Control of Enzymatic Carbon-Carbon Bond-Forming Michael-Type Additions by "Substrate Engineering".

Authors:  Yufeng Miao; Pieter G Tepper; Edzard M Geertsema; Gerrit J Poelarends
Journal:  European J Org Chem       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.